From diagnosis to cure.
It is only a matter of time before man succeeds in his mechanisms linked to the harnessing of energy.
- Nikola Tesla -
Paso Alto Biophysics | More than a biotech company.
Paso Alto Biophysics & Biomedical Engineering is a company specialising in biophysical science and medical bioengineering research that works to develop new systems for the treatment of diseases and their subsequent transfer to the industrial sector, in other words, it carries out frontier science to develop new technologies to help implement the medicine of the future.
In this first stage, we are focused on developing new systems of therapies or
methods that can be applied in processes to combat infectious diseases.
The company carries out its research and technological development work without belonging to any pharmaceutical structure, nor is it housed in centres, organisations or administrations of any kind, so that all the advances achieved in the different areas of action belong exclusively to it, which in turn enables it to develop without being answerable to any external agent.
Biophysics & Biomedical
During the development of our scientific research we have achieved the following milestones.
The technical device"Prototype I"
Prototype I", a device capable of interacting with RNA-type viruses contained in its characteristic media, is completed.
Laboratory inactivation of Zika, Ross River and Yellow Fever viruses.
Experiments are carried out at research institutes such as ICIII (Carlos III Health and Research Institute of Madrid), where in vitro inactivation of Zika, Ross River and Yellow Fiver virus samples is achieved using the "Prototype I" device.
Development of the "Prototype II"
Development of "Prototype II" is completed. Device capable of interacting with RNA and DNA viruses contained in its characteristic media.
African swine fever virus (ASFV) in vitro test.
Experiments with "Prototype II" at the CBMSO (Severo Ochoa Molecular Biology Centre in Madrid) and for the first time, two ASFV vaccine candidates are obtained with Modulated Molecular Interaction Technology (MMITech).
Clinical trial with ASFV vaccine candidates.
Clinical animal trial begins with ASFV vaccine candidates obtained through MMITech at veterinary research laboratory in Lelystad, The Netherlands.
Founder & CEO
Specialist in physical sciences and electronics.
CEO and Director of Research and Development at
Paso Alto Biophysics and Biomedical Engineering.
Fundador & President.
Studies in economics, risk analyst and specialist in intellectual and industrial property in the biotechnology sector with experience in the banking sector.Current President and CFO of Paso Alto Biophysics and Biomedical Engineering.
Mentions and recognitions.
A company from the Canary Islands is collaborating in the creation of a vaccine against the coronavirus.
Publication date - 02/13/2020
We don't follow trends,
at Paso Alto Biophysics we
This new methodology has the potential to significantly advance medical science and the health sector.
Molecular physics and
electronics in the service
A company dedicated to
research in biophysical
science and bioengineering.
Paso Alto Biophysics &
© 2022 Paso Alto by - All Rights Reserved
(0034) 922 892 844
Santa Cruz, Tenerife
Islas Canarias, España.